510(k) Report

510(k) · Cleared

Cleared

Tru Flu

K071657510(k) TraditionalCleared Nov 15, 2007150-day reviewClass II21 CFR 866.3328

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Meridian Bioscience, Inc. · PSZ Devices Detecting Influenza A, B, And C Virus Antigens

Cleared on Nov 15, 2007 as substantially equivalent to K041626 (Meridian Bioscience, Inc., 2005) and 1 other predicate after a 150-day review. Its family tree reaches back 5 generations to 1990.

Decided
Nov 15, 2007
Review
150 days
Class
Class II
Product code
PSZ
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K902609 (1990). 12 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2006: 1 other ancestor2003: 1 other ancestor2002: 2 other ancestors2000: 1 other ancestor1998: 1 other ancestor1999: 1 other ancestorK902609 · Directigen Flu a · Bd Becton Dickinson Vacutainer Systems Preanalytic · 1990K981651 · AB Flu Oia · Biostar, Inc. · 1998K023556 · Flu Oia a/B Test Kit · Thermo Biostar, Inc. · 2003 · recalledK031899 · Quickvue Influenza a+B Test · Quidel Corp. · 2003K041626 · Immunocard Stat! Flu a & B · Meridian Bioscience, Inc. · 20051990199520002005
  1. Root · 5 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
  2. 4 generations backK981651 AB Flu OiaBiostar, Inc. · 1998
  3. 3 generations backK023556 Flu Oia a/B Test KitThermo Biostar, Inc. · 2003 · Recalled
  4. 2 generations backK031899 Quickvue Influenza a+B TestQuidel Corp. · 2003
  5. 1 generation backK041626 Immunocard Stat! Flu a & BMeridian Bioscience, Inc. · 2005
  6. This deviceK071657 Tru FluMeridian Bioscience, Inc. · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K902609Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic1990—
−4K981651AB Flu OiaBiostar, Inc.1998—
−3K023556Flu Oia a/B Test KitThermo Biostar, Inc.20031
−2K031899Quickvue Influenza a+B TestQuidel Corp.2003—
−1K041626Immunocard Stat! Flu a & BMeridian Bioscience, Inc.2005—
0 (this device)K071657Tru FluMeridian Bioscience, Inc.2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
199910
200010
200220
200310
200610
FIG. 1 — Lineage of K071657, 1990–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PSZ device

  1. #1 K252283 Nano-Check Influenza A+B Testscore 14.9 · 15 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K041626Immunocard Stat! Flu a & B
Summary page 1
…er clinical management decisions. PREDICATE DEVICES: TRU FLU is a modification of, and is intended to detect the same analytes as, ImmunoCard STAT! Flu A&B PLUS (K041626), Meridian Bioscience, Inc. Binax NOW Influenza A&B, Inverness Medical (K062109) BACKGROUND: Influenza is a highly contagious, e…
Meridian Bioscience, Inc.2005—
*K062109Binaxnow Influenza a & B Test
Summary page 1
…of, and is intended to detect the same analytes as, ImmunoCard STAT! Flu A&B PLUS (K041626), Meridian Bioscience, Inc. Binax NOW Influenza A&B, Inverness Medical (K062109) BACKGROUND: Influenza is a highly contagious, epidemic to pandemnic acute viral respiratory disease caused by several genera of…
Binax, Inc.20062

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 5 companies; a new generation was cleared every 2.7 years on median.
  • 2 of the 12 ancestors have a recall of any class.

How does its category compare?

All PSZ devices

PSZ Devices Detecting Influenza A, B, And C Virus Antigens: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · PSZ

2in 2025

2007: 22008: 12009: 72010: 52011: 32012: 22013: 82014: 12015: 42016: 32017: 32018: 52020: 22023: 22025: 22026 (partial year): 2
2007high 8 (2013) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSZ

28in 2018

2009: 20 days median2010: 29 days median2011: 80 days median2013: 28 days median2015: 27 days median2016: 29 days median2017: 200 days median2018: 28 days median
2007high 200 (2017) · low 20 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PSZ

1in 2022

2020: 12022: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PSZ

60in 2025

2018: 12019: 12020: 52021: 422022: 102023: 122024: 162025: 60
2007high 60 (2025) · low 0 (2007)2025

MAUDE reports naming product code PSZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
200972000
201052900
201138000
20122—00
201382800
20141—00
201542700
201632900
2017320000
201852801
20190—01
20202—15
20210—042
20220—110
20232—012
20240—016
20252—060
20262—0—

What is it indicated for?

TRU FLU is a rapid, qualitative, lateral-flow immunochromatographic assay for detecting both influenza A and influenza B viral nucleoprotein antigens in human nasal wash, nasopharyngeal aspirate and nasal and nasopharyngeal swab samples in symptomatic patients. This test is not intended for the detection of influenza C viruses. A negative test is presumptive and it is recommended these results be confirmed by cell culture. Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other clinical management decisions.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K071657: Tru Flu.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K071657

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026